Febuxostat
Price | Get Latest Price |
Package | 1kg |
Min. Order: | 1kg |
Supply Ability: | 20tons |
Update Time: | 2023-09-14 |
Product Details
Product Name: Febuxostat | CAS No.: 144060-53-7 |
EC-No.: 682-158-6 | Min. Order: 1kg |
Purity: 99.87% | Supply Ability: 20tons |
Release date: 2023/09/14 |
Application:
Gout Treatment: Febuxostat is primarily used in the treatment of gout, a form of arthritis caused by the buildup of uric acid crystals in the joints. Febuxostat works by inhibiting xanthine oxidase, an enzyme involved in the production of uric acid. By reducing the production of uric acid, Febuxostat helps to lower the levels of uric acid in the blood, preventing the formation of crystals and alleviating gout symptoms.
Hyperuricemia: Hyperuricemia refers to high levels of uric acid in the blood, which can lead to the development of gout. Febuxostat can be used to manage hyperuricemia, either as a standalone treatment or in combination with other medications. By inhibiting xanthine oxidase, Febuxostat helps to regulate uric acid levels and prevent its excessive buildup.
Tumor Lysis Syndrome (TLS): TLS is a potential complication that can occur in cancer patients undergoing chemotherapy. It results from the rapid breakdown of cancer cells, leading to the release of large amounts of uric acid into the bloodstream. Febuxostat can be used as part of the management of TLS to reduce uric acid levels and prevent associated complications, such as kidney damage and gout.
Chronic Kidney Disease: Febuxostat has been investigated for its potential in managing hyperuricemia in patients with chronic kidney disease (CKD). CKD is often associated with elevated uric acid levels, which can contribute to the progression of kidney damage. By lowering uric acid levels, Febuxostat may help slow the progression of kidney disease and reduce the risk of associated complications.
Cardiovascular Health: Some research suggests that reducing uric acid levels with Febuxostat may have cardiovascular benefits. Elevated uric acid levels have been linked to an increased risk of cardiovascular disease, including hypertension, coronary artery disease, and stroke. By managing hyperuricemia, Febuxostat may potentially have a positive impact on cardiovascular health, although further studies are needed to establish its efficacy in this area.
If you need similar products, please contact my email : admin04@hsnm.com.cn
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$150.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-11-28 | |
$1.00/1KG |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-11-25 | |
$32.00/5mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$32.00/5mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-11-15 | |
$0.00/1kg |
VIP5Y
|
Jinan Jianfeng Chemical Co., Ltd
|
2024-08-09 | |
$6.00/1kg |
VIP1Y
|
hebei hongtan Biotechnology Co., Ltd
|
2024-05-13 | |
$50.00/1kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-15 | ||
$90.00/1kg |
VIP2Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2023-10-30 | |
$0.00/10gkg |
VIP2Y
|
shan dong Fengjin Pharmaceutical company
|
2023-09-26 |
- Since: 2022-09-29
- Address: Room 401, 4th Floor, No. 3-1 Factory Building, Guandong Science and Technology Industrial Park, Jiay